Figure 2.

Expression of the KMP1 epitope is consistent with clinical severity and prognosis of patients with bladder cancer. (A) The expression level of the KMP1 epitope is in agreement with clinical severity. Serial sections of bladder cancer biopsies were stained with KMP1 by immunohistochemistry analysis. Normal bladder biopsy from a healthy person was not stained with KMP1. (B) Relationship between the expressions of KMP1 epitope and prognosis in radical cystectomy patients. The patients with high expressions of the KMP1 epitope had significantly worse prognosis than those with low expressions of the KMP1 epitope (P = 0.0027); n, patient number.